Skip to main content

Table 1 Clinical parameters of Hct, PF-4, β-TG, FDP, d-dimer, and change ratio of FIB

From: Biocompatibility and small protein permeability of hydrophilic-coated membrane dialyzer (NV) in hemodialysis patients: a pilot study

   0 (min) 30 (min) 60 (min) 240 (min)
Hct (%) NV 32.2 ± 2.4 31.4 ± 2.7 32.1 ± 2.6 34.9 ± 3.3
APS 32.0 ± 2.4 30.9 ± 2.3 31.5 ± 2.3 34.4 ± 2.8
PF-4 (ng/mL) NV 7.45 ± 7.09 29.2 ± 13.5 16.9 ± 8.1 12.3 ± 7.4
APS 6.77 ± 3.69 32.3 ± 21.5 17.3 ± 6.9 12.1 ± 5.8
β-TG (ng/mL) NV 146 ± 41 128 ± 42 118 ± 36 104 ± 39
APS 135 ± 33 125 ± 40 119 ± 36 101 ± 30
FDP (μg/mL) NV 2.0(2.0, 2.0) 2.0(2.0, 2.0) 2.0(2.0, 2.0) 2.0(2.0, 3.0)
APS 2.0(2.0, 2.0) 2.0(2.0, 2.0) 2.0(2.0, 3.0) 2.0(2.0, 2.0)
d-dimer (μg/mL) NV 0.4(0.2, 0.5) 0.3(0.2, 0.5) 0.3(0.2, 0.5) 0.4(0.2, 0.5)
APS 0.4(0.4, 0.5) 0.3(0.2, 0.5) 0.3(0.2, 0.5) 0.3(0.2, 0.5)
Change ratio of FIB (%) NV 98.6 ± 2.8 102 ± 3 117 ± 8
APS 97.8 ± 3.3 101 ± 4 116 ± 11
  1. FDP and d-dimer are expressed as medians with 25th–75th percentiles
  2. Hct hematocrit, PF-4 platelet factor-4, β-TG thromboglobulin, FDP fibrinogen/fibrin degradation products, FIB fibrinogen